GleanMark

REPORTUM Trademark

REPORTUM is a USPTO trademark filed by MyMedsandMe Limited. Status: Registered.

Trademark Facts

MarkREPORTUM
Serial Number79141292
Registration Number4562037
StatusRegistered
Filing Date2013-07-25
Registration Date2014-07-08
Mark TypeWord
Nice Classes009 (Electronics & Software), 038 (Telecommunications), 042 (Software & IT)
OwnerMyMedsandMe Limited
Attorney of RecordAlexis P. Grilli
Prosecution Events39
Latest EventNA71 on 2025-05-18

Goods & Services

Computer software for capturing information concerning reactions and events resulting from the use of medication and/or pharmaceuticals, enabling follow-up questions and answers regarding said reactions and events and producing reports regarding such reactions and events; computer programs for capturing information concerning reactions and events resulting from the use of medication and pharmaceuticals, for enabling follow-up questions and answers regarding said reactions and events and for producing reports regarding such reactions and events; computer software applications for capturing information concerning reactions and events resulting from the use of medication and pharmaceuticals, for enabling follow-up questions and answers regarding said reactions and events and for producing reports regarding such reactions and events; Telecommunications services, namely, transmission by means of telecommunications networks, wireless communication networks and the Internet of information, data and reports concerning reactions and events arising from the use of medication and pharmaceuticals; providing access to online databases which capture data relating to reactions and events arising from the use of medication and pharmaceuticals, enable follow up questions regarding such reactions and events and contain reports regarding said reactions and events; data transmission and reception services via telecommunication means, namely, data transmission and reception services relating to reactions and events arising from the use of medication and pharmaceuticals; telecommunication services, namely, providing access between patients or health care professionals and pharmaceutical companies to an electronic exchange of medical records concerning reactions and events arising from the use of medication and pharmaceuticals via a global computer network; Software as a service (SAAS) services featuring software for capturing information concerning reactions and events resulting from the use of medication and/or pharmaceuticals, for enabling follow up questions and answers regarding said reactions and events and for producing reports regarding such reactions and events; providing temporary use of on-line non-downloadable software which enables the capture of information concerning reactions and events resulting from the use of medication and/or pharmaceuticals, as well as enabling follow-up questions and answers regarding said quality, reactions and events and enables the production of reports regarding said reactions and events; maintenance of computer software which enables the capture of information concerning reactions and events resulting from the use of medication and/or pharmaceuticals and enables follow-up questions and answers regarding said reactions and events

Related